The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTI1.L Regulatory News (TI1)

  • There is currently no data for TI1

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

October NAV & Company Share Repurchases

30 Nov 2021 07:00

RNS Number : 9502T
Trian Investors 1 Limited
30 November 2021
 

30 November 2021

 

TRIAN INVESTORS 1 LIMITED

(the "Company")

 

Net Asset Value as at 31 October 2021 and Announcement of Company Share Repurchases

 

Net Asset Value as at 31 October 2021

The Company is pleased to announce its Net Asset Value as at 31 October 2021 was £469.81 million, or 185.39 pence per Ordinary Share (each, a "Share").

 

Company Share Repurchases

On 10 December 2021, Trian Investors 1, L.P. (the "Investment Partnership") expects to receive a dividend from Ferguson plc ("Ferguson") of 123.78 pence per Ferguson ordinary share. In connection with the foregoing, the Board today announces that the Company intends to use £3.7 million ($5 million) in excess cash reserves expected to be distributed by the Investment Partnership, to repurchase Shares of the Company (the "Share Repurchases"), as and when the Board deems it to be in the best interests of the Company, with a view to, among other things, managing imbalances between the supply and demand for Company Shares. The Board retains absolute discretion as to the execution, pricing and time of the Share Repurchases, subject to the conditions set out in the authority to make market purchases conferred at the Company's 2021 annual general meeting (the "2021 AGM"), and there should be no presumption that the Share Repurchases will form part of an ongoing programme. The Company intends that any Shares bought back through the Share Repurchases will be held in treasury.

After considering the prevailing discount to Net Asset Value at which the Company's Shares currently trade, the Board believes that using excess cash reserves resulting from the Ferguson dividend to fund share repurchases, as opposed to a dividend, would provide the greater benefit to continuing Company shareholders, and is consistent with the Board's intention as set forth in the Interim Report for the period from 1 January 2021 to 30 June 2021 and the feedback received from shareholders following the Company's 2021 AGM.

For further information, please contact:

 

Ocorian Administration (Guernsey) Limited(Administrator and Company Secretary)+44 (0)1481 742 742Ian Smith

 

Numis Securities Limited

(Joint corporate broker) 

+44 (0)20 7260 1000

David Benda

 

Jefferies International Limited

(Joint corporate broker)

+44 (0)20 7029 8000

Stuart Klein

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NAVEAPFNASNFFFA
Date   Source Headline
26th Apr 20234:22 pmRNSNotice of EGM Results
26th Apr 20234:21 pmRNSNotice of AGM Results
26th Apr 20237:30 amRNSSuspension - Trian Investors 1 Limited
17th Apr 20235:03 pmRNSNet Asset Value as at 31 March 2023
6th Apr 20232:55 pmRNSHolding(s) in Company
3rd Apr 20237:00 amRNSTotal Voting Rights
24th Mar 20237:01 amRNSNotice of EGM
24th Mar 20237:00 amRNSNotice of AGM
22nd Mar 20237:00 amRNSDirector/PDMR Shareholding
17th Mar 20237:00 amRNSAnnual Report to 31 December 2022
16th Mar 202312:08 pmRNSNAV as at 28 February 2023 and as at 13 March 2023
14th Mar 20232:43 pmRNSTotal Voting Rights
2nd Mar 20237:00 amRNSCompulsory Share Redemption Update
22nd Feb 20232:53 pmRNSNet Asset Value as at 16 February 2023
22nd Feb 20232:37 pmRNSNet Asset Value as at 31 January 2023
17th Feb 20237:00 amRNSCompulsory Share Redemption Update
1st Feb 20237:00 amRNSTotal Voting Rights
19th Jan 20237:00 amRNSNet Asset Value as at 6 January 2023
19th Jan 20237:00 amRNSIn-specie Distribution & Complusory Redemption
9th Jan 20236:01 pmRNSNet Asset Value as at 31 December 2022
9th Jan 20237:00 amRNSCompulsory Share Redemption Update
14th Dec 20225:26 pmRNSNet Asset Value as at 30 November 2022
11th Nov 20224:34 pmRNSNet Asset Value as at 31 October 2022
26th Oct 20225:16 pmRNSReplacement - Net Asset Value(s)
25th Oct 20224:16 pmRNSNet Asset Value as at 30 September 2022
24th Oct 20228:51 amRNSHolding(s) in Company
15th Sep 20227:00 amRNSInterim Results
14th Sep 20227:00 amRNSNet Asset Value as at 31 August 2022
6th Sep 202210:42 amRNSHolding(s) in Company
2nd Sep 20227:00 amRNSCompulsory Share Redemption by 30 June 2023
15th Aug 20225:30 pmRNSChanges to Director Roles and Responsibilities
12th Aug 20227:00 amRNSNet Asset Value as at 31 July 2022
8th Aug 20227:00 amRNSResult of EGM
8th Aug 20227:00 amRNSDirector Changes
8th Aug 20227:00 amRNSResult of AGM
11th Jul 20222:01 pmRNSNotice of AGM
11th Jul 20222:00 pmRNSNotice of Requisitioned EGM
11th Jul 20227:00 amRNSNet Asset Value as at 30 June 2022
1st Jul 20227:00 amRNSTotal Voting Rights
21st Jun 20227:00 amRNSTransaction in Own Shares
20th Jun 20223:56 pmRNSReceipt of Requisition Notice
15th Jun 20227:00 amRNSNet Asset Value as at 31 May 2022
31st May 20228:00 amRNSInvestment in Unilever
6th May 20226:00 pmRNSNet Asset Value as at 30 April 2022
14th Apr 20227:01 amRNSDirector Appointment
14th Apr 20227:00 amRNSAnnual Report to 31 December 2021
13th Apr 20225:53 pmRNSNet Asset Value as at 31 March 2022
29th Mar 202210:11 amRNSNew US$100m Revolving Credit Facility
16th Mar 20224:53 pmRNSNet Asset Value as at 28 February 2022
1st Mar 20227:00 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.